We Give Shareholders a Voice
Levi & Korsinsky is investigating the Board of Directors of Medivation, Inc. (NASDAQ: MDVN) (“Medivation” or “the Company”) in connection with the sale of the Company to Pfizer Inc. (NYSE: PFE). Under the terms of the transaction, Medivation shareholders will receive $81.50 for each share of Medivation stock they own.
The investigation concerns whether the Board of Medivation breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Pfizer Inc. is underpaying for Medivation shares.
To receive more information, please fill out the form.